Lotus Pharmaceuticals Stock Analysis

Lotus Pink Sheet Analysis Notes

The company has price-to-book ratio of 0.01. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Lotus Pharmaceuticals had not issued any dividends in recent years. The entity had 1:2 split on the 31st of December 2010. Lotus Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the development, manufacture, and sale of pharmaceuticals in the Peoples Republic of China. Lotus Pharmaceutical operates under Shell Companies classification in the United States and is traded on OTC Exchange. It employs 233 people.The quote for Lotus Pharmaceuticals is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Lotus Pharmaceuticals contact Zhongyi Liu at 615 310 2688 or learn more at https://lotuspharmaceuticalsusa.com.

Lotus Pharmaceuticals Investment Alerts

Lotus Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 834.49 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Lotus Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Lotus Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Lotus Profitablity

The company has Profit Margin (PM) of 0.02 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.11 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.11.

Technical Drivers

As of the 18th of April 2024, Lotus Pharmaceuticals secures the Risk Adjusted Performance of 0.0963, mean deviation of 7.15, and Downside Deviation of 25.97. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Lotus Pharmaceuticals, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We are able to break down and analyze data for nineteen technical drivers for Lotus Pharmaceuticals, which can be compared to its peers in the industry. Please verify Lotus Pharmaceuticals information ratio and downside variance to decide if Lotus Pharmaceuticals is priced some-what accurately, providing market reflects its recent price of 0.007 per share. As Lotus Pharmaceuticals appears to be a penny stock we also strongly suggest to check its total risk alpha numbers.

Lotus Pharmaceuticals Price Movement Analysis

Lotus Pharmaceuticals Predictive Daily Indicators

Lotus Pharmaceuticals Forecast Models

Lotus Pharmaceuticals' time-series forecasting models are one of many Lotus Pharmaceuticals' pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Lotus Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Lotus Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Lotus shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Lotus Pharmaceuticals. By using and applying Lotus Pink Sheet analysis, traders can create a robust methodology for identifying Lotus entry and exit points for their positions.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lotus Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

When running Lotus Pharmaceuticals' price analysis, check to measure Lotus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lotus Pharmaceuticals is operating at the current time. Most of Lotus Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Lotus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lotus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Lotus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.